Skip to main content
Amar Kelkar, MD, Hematology, Boston, MA, Brigham and Women's Hospital

AmarKelkarMDMPH FACP(He/Him)

Hematology • Boston, MA

Hematologic Oncology

Instructor in Medicine

Join to view full profile

Dr. Kelkar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kelkar's full profile

Already have an account?

Summary

  • Dr. Amar Kelkar is a Stem Cell Transplantation Physician at the Dana-Farber Cancer Institute and an Instructor in Medicine at Harvard Medical School. He sees patients for allogeneic transplantation and cell and gene therapy, treating many blood disorders including leukemia and sickle cell disease. He also directs the BMT Survivorship Clinic.

    He is a member of the Abel Laboratory with research interests in hematology, care delivery, health economics, medical ethics, public health, and health policy. He completed an MPH in Clinical Effectiveness at the Harvard T.H. Chan School of Public Health in 2023 and received the ASTCT New Investigator Award in 2024. His work has been published in journals including the New England Journal of Medicine, Annals of Internal Medicine, and the Journal of Clinical Oncology, as well as in STAT Opinion. He also has interests in health policy and medical advocacy and serves on the American Society of Hematology Committee on Practice and Subcommittee on Reimbursement, the American Society for Transplantation and Cellular Therapy Value and Health Economics Special Interest Group, and the Massachusetts Medical Society (MMS) Committee on Publications that oversees the NEJM Group. He previously served on the MMS Board of Trustees, the American Medical Association (AMA) Council on Legislation, and was the AMA Resident and Fellow Section Governing Council Delegate to the House of Delegates.

    His background is in molecular biology and genetics with a degree from Cornell University in Biological Sciences, where he worked for 3 years as a member of the Andrew Clark Laboratory focused on population genetics. He completed postgraduate medical training at the University of Illinois College of Medicine at Peoria, the University of Florida College of Medicine, and the Dana-Farber Cancer Institute.

Education & Training

  • Harvard School of Public Health
    Harvard School of Public HealthMaster of Public Health, Clinical Effectiveness, 2021 - 2023
  • Dana-Farber Cancer Institute
    Dana-Farber Cancer InstituteStem Cell Transplantation, 2021 - 2022
  • University of Florida
    University of FloridaFellowship, Hematology and Medical Oncology, 2018 - 2021
  • University of Illinois College of Medicine at Peoria
    University of Illinois College of Medicine at PeoriaChief Residency, Internal Medicine, 2017 - 2018
  • University of Illinois College of Medicine at Peoria
    University of Illinois College of Medicine at PeoriaResidency, Internal Medicine, 2015 - 2018
  • St. George's University School of Medicine
    St. George's University School of MedicineClass of 2015
  • Cornell University
    Cornell UniversityBS, Biological Sciences, Genetics & Development, 2006 - 2010

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2021 - 2025
  • FL State Medical License
    FL State Medical License 2018 - 2022
  • IL State Medical License
    IL State Medical License 2015 - 2018
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Gold Humanism Honor Society The Arnold P. Gold Foundation, 2014

Publications & Presentations

PubMed

Abstracts/Posters

  • Cytomegalovirus Induced Portal Vein Thrombosis: An Underreported Association
    A.H. Kelkar, S.B. Sreenivasappa, K. Subramanian, J.J. Farrell, ASM Microbe 2017, New Orleans, LA, USA, 6/2/2017
  • Hematophagocytic Lymphohistiocytosis Presenting as Acute Liver Failure
    Ahmed Z, Kelkar AH, Shah AA, Yong SL, American College of Gastroenterology 2016: Annual Scientific Meeting & Postgraduate Course, Las Vegas, NV, USA, 10/17/2017
  • A forgotten but common cause of hypokalemia
    Martial A, Roy M, Kelkar A, Rosenbaum K, American College of Physicians Downstate Illinois Chapter Meeting 2016, Champaign, IL, USA, 11/18/2016
  • Join now to see all

Authored Content

  • Specialized Centers Can Help Realign the U.S.’s Moral Compass for Sickle Cell DiseaseDecember 2022

Press Mentions

  • Specialized Centers Can Help Realign the U.S.’s Moral Compass for Sickle Cell Disease
    Specialized Centers Can Help Realign the U.S.’s Moral Compass for Sickle Cell DiseaseDecember 21st, 2022
  • ‘Time Is Blood’: Researchers Devise Shortcut to AHA Diagnosis
    ‘Time Is Blood’: Researchers Devise Shortcut to AHA DiagnosisApril 18th, 2022
  • #PWChat: The Status of Mental Healthcare in the US
    #PWChat: The Status of Mental Healthcare in the USMarch 26th, 2021
  • Join now to see all

Other Languages

  • Marathi

Hospital Affiliations

External Links

Dr. Amar Kelkar, Dr. Amar Kelkar, MD, Dr. A Kelkar